Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2011 Jun 9;364(23):2268-70.
doi: 10.1056/NEJMc1101502#SA1.

Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine

Case Reports

Drugs and pheochromocytoma--don't be fooled by every elevated metanephrine

Nicola M Neary et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Mechanisms of Pharmacologic Interference with Catecholamines and Metanephrines
Sympathomimetic agents such as ephedrine, amphetamine, caffeine, and nicotine increase the release of norepinephrine and epinephrine. Monoamine oxidase (MAO) inhibitors block the conversion of norepinephrine and epinephrine to dihydroxyphenylglycol (DHPG), leading to increased concentrations and availability of these two catecholamines. Drugs that inhibit norepinephrine and epinephrine reuptake, such as serotonin–norepinephrine reuptake inhibitors (e.g., venlafaxine), “selective” serotonin-reuptake inhibitors, and tricyclic antidepressants, lead to increased concentrations of norepinephrine and epinephrine in the synaptic clefts. The α-adrenergic-receptor blockers and β-adrenergic-receptor blockers reduce the effects of catecholamines on end organs such as the brain, heart, gastrointestinal tract, and others. DOPA denotes dihydroxyphenylalanine.

Similar articles

Cited by

References

    1. Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 2001;69:49–54.. [Erratum, Am J Hum Genet 2002; 70:565.]

    1. Eisenhofer G, Goldstein DS, Walther MM, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab. 2003;88:2656–66. - PubMed
    1. Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab. 2007;92:4069–79. - PubMed
    1. Harvey AT, Rudolph RL, Preskorn SH. Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry. 2000;57:503–9. - PubMed
    1. Grassi G, Seravalle G, Calhoun DA, Bolla G, Mancia G. Cigarette smoking and the adrenergic nervous system. Clin Exp Hypertens A. 1992;14:251–60. - PubMed